Table 3.

Aggregated dose-response data of five clinical trials investigating effectiveness of different dosages of aripiprazole in schizoaffective patients. The continuous outcome is measured on the Positive and Negative Syndrome Scale and summarized by mean values (mean(Y)) and standard deviations (sd(Y))

ID	Author, Year	dose	mean(Y)	sd(Y)	n	d	Var(d)
1	Cutler, 2006 [28]	0	5.300	18.310	85	0.000	0.000
		2	8.230	18.320	92	2.930	7.593
		5	10.600	18.310	89	5.300	7.715
		10	11.300	18.320	94	6.000	7.515
2	McEvoy, 2007 [29]	0	2.330	26.100	107	0.000	0.000
		10	15.040	27.600	103	12.710	13.344
		15	11.730	26.200	103	9.400	13.344
		20	14.440	25.900	97	12.110	13.764
3	Kane, 2002 [30]	0	2.900	24.280	102	0.000	0.000
		15	15.500	26.490	99	12.600	12.038
		30	11.400	22.900	100	8.500	11.977
4	Potkin, 2003 [31]	0	5.000	21.140	103	0.000	0.000
		20	14.500	20.160	98	9.500	8.563
		30	13.900	20.880	96	8.900	8.654
5	Study 94202 [32]	0	1.400	25.730	57	0.000	0.000
		2	11.000	25.000	51	9.600	25.447
		10	11.500	25.200	51	10.100	25.447
		30	15.800	28.510	54	14.400	24.701